Human cytomegalovirus evasion of natural killer cell functions (360G-Wellcome-079591_Z_06_Z)

£250,076

Human cytomegalovirus (HCMV) provides a paradigm for how a complex viral pathogen persists and evades immune responses. HCMV evades cytotoxic T cells by downregulating class I MHC, but then has to evade natural killer (NK) cells. We have recently described a novel MHC-like gene unique to clinical isolates that inhibits NK cell lysis in a clonally dependant manor. The specific goals of the work proposed are to: (i)Define the mechanism of action of the novel viral NK evasion gene product (UL142) by identifying its ligand and how this mediates evasion of NK cell cytotoxicity.(ii)Construct deletion mutants of HCMV, for UL142 and other NK evasion genes, using Bacterial Artificial Chromosome (BAC) methodology , and use NK cell clones to determine whether CMV encodes further proteins, which mediate NK cell evasion. We will use these BAC-HCMV mutants to determine if the known evasion genes are redundant or directed at NK clone subsets, (this might explain why HCMV encodes multiple mechanisms to evade NK cells). (iii) Investigate subjects with HCMV infection to determine whether infection with HCMV shapes the expressed NK cell receptor repertoire. (iv)Determine if HCMV proteins can functionaly interact with NK receptors on HCMV specific CD8+ cells impairing effector function.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 250076
Applicant Surname Wills
Approval Committee Immunology and Infectious Disease Funding Committee
Award Date 2006-04-24T00:00:00+00:00
Financial Year 2005/06
Grant Programme: Title Project Grant
Internal ID 079591/Z/06/Z
Lead Applicant Dr Mark Wills
Partnership Value 250076
Planned Dates: End Date 2010-01-31T00:00:00+00:00
Planned Dates: Start Date 2006-11-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region East of England